SCHEMBL22043777

SCHEMBL22043777

C/C(N)=N/N=C(\N)c1cccc(C)c1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.53
RAB9A P51151 13/20 0.47
NPC1 O15118 12/20 0.47
PKM P14618 4/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
HTT P42858 1/20 0.47
HDAC8 Q9BY41 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
L3MBTL1 Q9Y468 3/20 0.46
ATM Q13315 1/20 0.46
HPGD P15428 2/20 0.44
ALOX15 P16050 1/20 0.44
POLB P06746 1/20 0.44
LMNA P02545 1/20 0.44
TDP1 Q9NUW8 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22044441 0.87 PARP1 (0.55) PARP1RAB9ANPC1PKMSMN1; SMN2
SCHEMBL22044396 0.81 PARP1 (0.50) PARP1LMNATDP1
SCHEMBL21589373 0.81 PARP1 (0.53) PARP1RAB9ANPC1PKMSMN1; SMN2
SCHEMBL24022744 0.80 PARP1 (0.52) PARP1RAB9ANPC1PKMSMN1; SMN2
SCHEMBL22043792 0.79 PARP1 (0.50) PARP1RAB9ANPC1PKMSMN1; SMN2
SCHEMBL103984 0.79 PARP1 (0.59) PARP1RAB9ANPC1PKMSMN1; SMN2
SCHEMBL29478724 0.79 PARP1 (0.59) PARP1RAB9ANPC1PKMSMN1; SMN2
SCHEMBL6841043 0.79 PARP1 (0.59) PARP1RAB9ANPC1PKMSMN1; SMN2
SCHEMBL26234540 0.79 PARP1 (0.59) PARP1RAB9ANPC1PKMSMN1; SMN2
SCHEMBL103985 0.79 PARP1 (0.59) PARP1RAB9ANPC1PKMSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021228992-A1 NUCLIDE LABELLED H-TETRAZINES AND USE THEREOF FOR PET AND SPECT PRETARGETED IMAGING AND RADIONUCLIDE THERAPY RIGSHOSPITALET (DK) 2021-11-18 WO disclosed
EP-3909944-A1 NUCLIDE LABELLED H-TETRAZINES AND USE THEREOF FOR PET AND SPECT PRETARGETED IMAGING AND RADIONUCLIDE THERAPY Rigshospitalet (DK) 2021-11-17 EP disclosed
WO-2020108720-A1 NOVEL TETRAZINE COMPOUNDS FOR IN VIVO IMAGING Københavns Universitet (DK) 2020-06-04 WO disclosed